Seeking Alpha

Even as nearly everyone concedes Express Scripts' (ESRX) takeover of Medco (MHS) will receive...

Even as nearly everyone concedes Express Scripts' (ESRX) takeover of Medco (MHS) will receive the regulatory OK, Bloomberg figures there may still be time for "a nice trade to play." If the deal closes on March 30, traders who bought the stock at yesterday’s closing price would still enjoy a 91% annualized return, far ahead of any other major current deal.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs